Back
Actinium Pharmaceuticals Stock Price Chart

Former Zillow execs target $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
40
ATNM
Actinium Pharmaceuticals
Last Price:
$1.52
Seasonality Move:
2.2%
7 Day Trial
ALL ACCESS PASS
$
7

Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ATNM is experiencing slight selling pressure.
Actinium Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.47 | Sell |
20-day SMA: | 1.4 | Buy |
50-day SMA: | 1.37 | Buy |
200-day SMA: | 1.65 | Sell |
8-day EMA: | 1.47 | Sell |
20-day EMA: | 1.43 | Buy |
50-day EMA: | 1.38 | Buy |
200-day EMA: | 2.25 | Sell |
Actinium Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.04 | Buy |
Relative Strength Index (14 RSI): | 53.13 | Buy |
Chaikin Money Flow: | -50469 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.25 - 1.49) | Buy |
Bollinger Bands (100): | (1.13 - 1.45) | Buy |
Actinium Pharmaceuticals Technical Analysis
May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Actinium Pharmaceuticals Stock
Is Actinium Pharmaceuticals Stock a Buy?
-
Actinium Pharmaceuticals share price is 1.46 while ATNM 8-day simple moving average is 1.47, which is a Sell signal.
-
The stock price of ATNM is 1.46 while Actinium Pharmaceuticals 20-day SMA is 1.40, which makes it a Buy.
-
Actinium Pharmaceuticals 50-day simple moving average is 1.37 while ATNM share price is 1.46, making it a Buy technically.
-
ATNM stock price is 1.46 and Actinium Pharmaceuticals 200-day simple moving average is 1.65, creating a Sell signal.
ATNM Technical Analysis vs Fundamental Analysis
Sell
40
Actinium Pharmaceuticals (ATNM)
is a Sell
Is Actinium Pharmaceuticals a Buy or a Sell?
-
Actinium Pharmaceuticals stock is rated a SellThe current Actinium Pharmaceuticals [ATNM] share price is $1.46. The Score for ATNM is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
Actinium Pharmaceuticals Stock Info
Market Cap:
45.5M
Price in USD:
1.46
Share Volume:
160.9K
Actinium Pharmaceuticals 52-Week Range
52-Week High:
10.14
52-Week Low:
1.03
Sell
40
Actinium Pharmaceuticals (ATNM)
is a Sell
Actinium Pharmaceuticals Share Price Forecast
-
What is the Actinium Pharmaceuticals stock price today?The Actinium Pharmaceuticals stock price is 1.46 USD today.
-
Will ATNM stock go up or go down?Actinium Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Actinium Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Actinium Pharmaceuticals is overvalued.
Is Actinium Pharmaceuticals Stock a Buy?
-
Actinium Pharmaceuticals share price is 1.46 while ATNM 8-day exponential moving average is 1.47, which is a Sell signal.
-
The stock price of ATNM is 1.46 while Actinium Pharmaceuticals 20-day EMA is 1.43, which makes it a Buy.
-
Actinium Pharmaceuticals 50-day exponential moving average is 1.38 while ATNM share price is 1.46, making it a Buy technically.
-
ATNM stock price is 1.46 and Actinium Pharmaceuticals 200-day simple moving average is 2.25, creating a Sell signal.
Fundamental Analysis of Actinium Pharmaceuticals
Is Actinium Pharmaceuticals a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, an increase next quarter of $0.68 per share, a decrease this year of $0.06 per share, and an increase next year of $0.71 per share.
Technical Analysis of Actinium Pharmaceuticals
Should I short Actinium Pharmaceuticals stock?
-
ATNM Moving Average Covergence Divergence (MACD) indicator is 0.04, suggesting Actinium Pharmaceuticals is a Buy
-
Actinium Pharmaceuticals Relative Strength Index (RSI) is 53.13, which suggest Actinium Pharmaceuticals is overbought
-
The Bollinger Bands (25) for Actinium Pharmaceuticals is (1.25 - 1.49), which suggest Actinium Pharmaceuticals is a Buy
-
The Bollinger Bands (100) for Actinium Pharmaceuticals is (1.13 - 1.45), which suggest Actinium Pharmaceuticals is a Buy
* Actinium Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.